Direct visualization of gastrointestinal tract with lanthanide-doped BaYbF5 upconversion nanoprobes

Biomaterials

Volumn 34, Issue 30, 2013, Pages 7444-7452

  Liu, Zhen ^a,b   Ju, Enguo ^a,b   Liu, Jianhua ^c   Du, Yingda ^d   Li, Zhengqiang ^d   Yuan, Qinghai ^c   Ren, Jinsong ^a   Qu, Xiaogang ^a  

^a CHANGCHUN INSTITUTE OF APPLIED CHEMISTRY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

^d JILIN UNIVERSITY   (China)

Author keywords

Binary contrast agent; Gastrointestinal tract; Low toxic; Multimodal imaging; Upconversion nanoprobes

Indexed keywords

CONTRAST AGENT; GASTROINTESTINAL TRACT; LOW-TOXIC; MULTI-MODAL IMAGING; UP-CONVERSION;

CONTRAST MEDIA; INFRARED DEVICES; NANOPARTICLES; TOXICITY; VISUALIZATION; X RAY ANALYSIS;

NANOPROBES;

IODINE; LANTHANIDE; NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BARIUM MEAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TRACT; HEMOLYSIS; IN VIVO STUDY; MOUSE; NANOPROBE; NONHUMAN; PRIORITY JOURNAL; RADIOGRAPHY;

BINARY CONTRAST AGENT; GASTROINTESTINAL TRACT; LOW-TOXIC; MULTIMODAL IMAGING; UPCONVERSION NANOPROBES;

ACRYLIC RESINS; ADMINISTRATION, ORAL; ANIMALS; BARIUM COMPOUNDS; FLUORIDES; GASTROINTESTINAL TRACT; HEP G2 CELLS; HUMANS; LANTHANOID SERIES ELEMENTS; MICE; MOLECULAR PROBES; MULTIMODAL IMAGING; NANOPARTICLES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TEMPERATURE; X-RAY DIFFRACTION; YTTERBIUM;

EID: 84880510276     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.06.060     Document Type: Article

References (58)

1. Jelicks L. Imaging the gastrointestinal tract of small animals. JNeuroparasitol 2010, 1. Article ID N100504.
2. Frøkjær J., Drewes A., Gregersen H. Imaging of the gastrointestinal tract-novel technologies. JWorld Gastroenterol 2009, 15:160-168.
3. Morgan C., Trought W., Oddson T., Clark W., Rice R. Ultrasound patterns of disorders affecting the gastrointestinal tract. Radiology 1980, 135:129-135.
4. Hahn P., Stark D., Lewis J., Saini S., Elizondo G., Weissleder R., et al. First clinical trial of a new superparamagnetic iron oxide for use as an oral gastrointestinal contrast agent in MR imaging. Radiology 1990, 175:695-700.
5. Levy A., Remotti H., Thompson W., Sobin L., Miettinen M. Anorectal gastrointestinal stromal tumors: CT and MR imaging features with clinical and pathologic correlation. Am J Roentgenol 2003, 180:1607-1612.
6. Peterson C., Anderson J., Hara A., Carenza J., Menias C. Volvulus of the gastrointestinal tract: appearances at multi-modality imaging. RadioGraphics 2009, 29:1281-1293.
7. Lee N., Choi S., Hyeon T. Nano-sized CT contrast agents. Adv Mater 2013, 25:2641-2660.
8. Hallouard F., Anton N., Choqiet P., Constantinesco A., Vandamme T. Iodinated blood pool contrast media for preclinical X-ray imaging applications-A review. Biomaterials 2010, 31:6249-6268.
9. deKrafft K., Xie Z., Cao G., Tran S., Ma L., Zhou O., et al. Iodinated nanoscale coordination polymers as potential contrast agents for computed tomography. Angew Chem Int Ed 2009, 48:9901-9904.
10. Wang H., Zheng L., Peng C., Guo R., Shen M., Shi X., et al. Computed tomography imaging of cancer cells using acetylated dendrimer-entrapped gold nanoparticles. Biomaterials 2011, 32:2979-2988.
11. Skotland T. Molecular imaging: challenges of bringing imaging of intracellular targets into common clinical use. Contrast Media Mol Imaging 2012, 7:1-6.
12. Yang J., Favazza C., Chen R., Yao J., Cai X., Maslov K., et al. Simultaneous functional photoacoustic and ultrasonic endoscopy of internal organs invivo. Nat Med 2012, 18:1297-1302.
13. Kircher M., Zerda A., Jokerst J., Zavaleta C., Kempen P., Mittra E., et al. Abrain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle. Nat Med 2012, 18:829-834.
14. Kim J., Piao Y., Hyeon T. Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem Soc Rev 2009, 38:372-390.
15. Cai W., Chen X. Nanoplatforms for targeted molecular imaging in living subjects. Small 2007, 3:1840-1854.
16. 4 nanocrystals as potential optical/magnetic multimodal bioprobes. JAm Chem Soc 2012, 134:1323-1330.
17. Yang H., Xia Y. Bionanotechnology: enabling biomedical research with nanomaterials. Adv Mater 2007, 17:3085-3087.
18. Jun Y., Lee J., Cheon J. Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew Chem Int Ed 2008, 47:5122-5135.
19. x core/shell nanoparticles for simultaneous magnetic resonance imaging and X-ray computed tomography. JAm Chem Soc 2012, 134:10309-10312.
20. Seo W., Lee J., Sun X., Suzuki Y., Mann D., Liu Z., et al. FeCo/graphitic-shell nanocrystals as advanced magnetic-resonance-imaging and near-infrared agents. Nat Mater 2006, 5:971-976.
21. 4 nanocrystals with efficient near-infrared to near-infrared downconversion photoluminescence for bioimaging applications. ACS Nano 2012, 6:2969-2977.
22. Liu Y., Ai K., Liu J., Yuan Q., He Y., Lu L. Ahigh-performance ytterbium-based nanoparticulate contrast agent for invivo X-ray computed tomography imaging. Angew Chem Int Ed 2012, 51:1437-1442.
23. 2S quantum dots in the second near-infrared region. Angew Chem Int Ed 2012, 51:9818-9821.
24. Gao X., Cui Y., Levenson R., Chung L., Nie S. Invivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969-976.
25. Rabin O., Perez J., Grimm J., Wojtkiewicz G., Weissleder R. An X-ray computed tomography imaging agent based on long-circulating bismuth sulphide nanoparticles. Nat Mater 2006, 5:118-122.
26. Oh M., Lee N., Kim H., Park S., Piao Y., Lee J., et al. Large-scale synthesis of bioinert tantalum oxide nanoparticles for X-ray computed tomography imaging and bimodal image-guided sentinel lymph node mapping. JAm Chem Soc 2011, 133:5508-5515.
27. Pan D., Schirra C., Senpan A., Schmieder A., Stacy A., Roessl E., et al. An early investigation of ytterbium nanocolloids for selective and quantitative "multicolor" spectral CT imaging. ACS Nano 2012, 6:3364-3370.
28. Kinsella J., Jimenez R., Karmali P., Rush A., Kotamraju V., Gianneschi N., et al. X-Ray computed tomography imaging of breast cancer by using targeted peptide-labeled bismuth sulfide nanoparticles. Angew Chem Int Ed 2011, 50:12308-12311.
29. 5 nanoparticles: novel binary contrast agent for high-resolution invivo X-ray computed tomography angiography. Adv Healthc Mater 2012, 1:461-466.
30. Pan D., Roessl E., Schlomka J., Caruthers S., Senpan A., Scott M., et al. Computed tomography in color: nanoK-enhanced spectral CT molecular imaging. Angew Chem Int Ed 2010, 49:9635-9639.
31. deKrafft K., Boyle W., Burk L., Zhou O., Lin W. Zr- and Hf-based nanoscale metal-organic frameworks as contrast agents for computed tomography. JMater Chem 2012, 22:18139-18144.
32. Yu S., Watson A. Metal-based X-ray contrast media. Chem Rev 1999, 99:2353-2377.
33. Liu Y., Ai K., Lu L. Nanoparticulate X-ray computed tomography contrast agents: from design validation to invivo applications. Acc Chem Res 2012, 45:1817-1827.
34. Shilo M., Reuveni T., Motiei M., Popovtzer R. Nanoparticles as computed tomography contrast agents: current status and future perspectives. Nanomedicine 2012, 7:257-269.
35. Zwicher C., Hering M., Langer R. Computed tomography with iodine-free contrast media. Eur Radiol 1997, 7:1123-1126.
36. 3 up-conversion nanoparticle as an invivo X-ray CT imaging contrast agent. Biomaterials 2012, 33:6748-6757.
37. 3+ up-conversion nanoprobes as high-performance contrast agents for multi-modality imaging. Biomaterials 2013, 34:1712-1721.
38. 4 upconversion nanocrystals via an OA/ionic liquid two-phase system for invivo dual-modality imaging. Adv Funct Mater 2011, 21:4470-4477.
39. 4-based upconversion nanophosphors with long-term validity for multimodal lymphatic imaging. Biomaterials 2012, 33:6201-6210.
40. 5:Yb/Er nanoprobes for multi-modal upconversion fluorescent, invivo X-ray computed tomography and biomagnetic imaging. Biomaterials 2012, 33:9232-9238.
41. 3+ nanoprobe for CT and NIR-to-NIR fluorescent bimodal imaging. Biomaterials 2012, 33:5384-5393.
42. 1 MRI contrast agent with large longitudinal relaxivity. JMater Chem B 2013, 1:629-638.
43. 3+ nanocrystals. Chem Mater 2009, 21:1847-1851.
44. Lin Y., Haynes C. Impacts of mesoporous silica nanoparticle size, pore ordering, and pore integrity on hemolytic activity. JAm Chem Soc 2010, 132:4834-4842.
45. Slowing I., Wu C., Vivero-Escoto J., Lin V. Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells. Small 2009, 5:57-62.
46. Wang F., Liu X. Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals. Chem Soc Rev 2009, 38:976-989.
47. Wang F., Deng R., Wang J., Wang Q., Han Y., Zhu H., et al. Tuning upconversion through energy migration in core-shell nanoparticles. Nat Mater 2011, 10:968-973.
48. Jayakumar M., Idris N., Zhang Y. Remote activation of biomolecules in deep tissues using near-infrared-to-UV upconversion nanotransducers. Proc Natl Acad Sci U S A 2012, 109:8483-8488.
49. Ang L., Lim M., Ong L., Zhang Y. Applications of upconversion nanoparticles in imaging, detection and therapy. Nanomedicine 2011, 6:1273-1288.
50. Mader H., Kele P., Saleh S., Wolfbeis O. Upconverting luminescent nanoparticles for use in bioconjugation and bioimaging. Curr Opin Chem Biol 2010, 14:582-596.
51. Kumar R., Roy I., Ohulchanskyy T., Vathy L., Bergey E., Sajjad M., et al. Invivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 2010, 4:699-708.
52. Xiong L., Yang T., Yang Y., Xu C., Li F. Long-term invivo biodistribution imaging and toxicity of polyacrylic acid-coated upconversion nanophosphors. Biomaterials 2010, 31:7078-7085.
53. 3 nanorods. Biomaterials 2013, 34:508-515.
54. Fu C., Liu T., Li L., Liu H., Chen D., Tang F. The absorption, distribution, excretion and toxicity of mesoporous silica nanoparticles in mice following different exposure routes. Biomaterials 2013, 34:2565-2575.
55. Yang K., Gong H., Shi X., Wan J., Zhang Y., Liu Z. Invivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administration. Biomaterials 2013, 34:2787-2795.
56. Cheng L., Yang K., Li Y., Zeng X., Shao M., Lee S., et al. Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy. Biomaterials 2012, 33:2215-2222.
57. Li M., Al-Jamal K., Kostarelos K., Reineke J. Physiologically based pharmacokinetic modeling of nanoparticles. ACS Nano 2010, 4:6303-6317.
58. Cheng L., Yang K., Shao M., Lu X., Liu Z. Invivo pharmacokinetics, long-term biodistribution and toxicology study of functionalized upconversion nanoparticles in mice. Nanomedicine 2011, 6:1327-1340.